Fouremm,
I will respectfully choose to not answer your questions but instead remind you and others that the MACE event risk per patient is not linear but tapers off over time. Based on the EXAMINE trial in high risk diabetic patients, the greatest risk of an individual patient experiencing a MACE event is during the first 6-9 months of the trial. After that the tapering of event occurrence was apparent. Because of this, I can't easily answer your question.
BearDownAZ